Anti-Human CA9 Recombinant Antibody_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CA9 Recombinant Antibody

Anti-Human CA9 Recombinant Antibody

产品编号

YR1222

别名

科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Girentuximab ( 吉妥昔单抗 ), Anti-CA9 Recombinant Antibody, Research Grade Girentuximab
Catalog Number	YR1222
Molecular Name	Girentuximab
CAS Number	916138-87-9
Target	CA9[Homo sapiens]
Antibody Isotype	IgG1 Kappa
Clonity	Monoclonal
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Girentuximab (trade name Rencarex) is a chimeric IgG1 monoclonal antibody to carbonic anhydrase IX (CAIX). CAIX is expressed on the surface of most renal cancer cells and is hypothesized to be on the surface of other tumor cells. It is investigational agent in clinical trials for renal cell carcinoma. Its development was suspended as a "naked" or unconjugated antibody during phase III trials due to efficacy.
Host	Mouse
Application	WB, FuncS, IF, Neut, ELISA, FCM, IP, PK, IHC, Activ
Remarks	This product is for research use only.

推荐产品

400-621-6806
614353794
周一至周五 8:30-18:00
0